Shortage of 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage of 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection is affecting availability, with no specific details on manufacturers or end date provided.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION.
What's in Shortage
The drug in shortage is 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION. This is the generic name provided, with no brand names listed. The dosage form is indicated as injection based on the drug name, and the current status is active, meaning the shortage is ongoing.
Which Manufacturers Are Affected
No manufacturers are specified in the available data, so there is no information on affected companies, their availability status, or any notes.
Why There's a Shortage
No specific reason for the shortage has been provided in the source data.
What Patients Should Do
Patients experiencing issues with obtaining this medication should talk to their pharmacist about availability options. They can also ask about potential alternatives, but should not make changes without consulting their healthcare provider. Additionally, if possible, contact the manufacturer if details become available. Remember, patients should always consult their healthcare provider for personalized advice and not rely on this article for medical decisions.
Source
This information is attributed to the FDA Drug Shortage Database.
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,146 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.